Anteris Technologies hails FDA early feasibility study approval for DurAVR™ By: TheNewswire.com December 06, 2022 at 13:00 PM EST Contact DetailsProactive InvestorsJonathan Jackson+61 413 713 744Jonathan@proactiveinvestors.com